228 related articles for article (PubMed ID: 18952428)
1. Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
van Baalen A; von Spiczak S; Stephani U; Fischer G
Neuromuscul Disord; 2008 Dec; 18(12):1005-6; author reply 1006. PubMed ID: 18952428
[No Abstract] [Full Text] [Related]
2. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
3. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
4. Critical care. Inotrope therapy.
Place B
Nurs Times; 1996 Aug 28-Sep 3; 92(35):55-7. PubMed ID: 8868896
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
[TBL] [Abstract][Full Text] [Related]
6. Can perindopril delay the onset of heart failure in duchenne muscular dystrophy?
Stöllberger C; Finsterer J
J Am Coll Cardiol; 2005 Nov; 46(9):1781; author reply 1782. PubMed ID: 16256886
[No Abstract] [Full Text] [Related]
7. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
8. The cul-de-sac at the end of the road.
Stevenson LW
J Card Fail; 2003 Jun; 9(3):188-91. PubMed ID: 12815568
[No Abstract] [Full Text] [Related]
9. Transient dobutamine-mediated pulsus alternans.
Kahn JH; Starling MR; Supiano MA
Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of noninvasive hemodynamic monitoring as a screening tool prior to initiation of inotrope infusion.
Littmann L; Lasater M
J Cardiovasc Manag; 1999; 10(2):29-30. PubMed ID: 10557910
[No Abstract] [Full Text] [Related]
11. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J
Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500
[TBL] [Abstract][Full Text] [Related]
12. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
López-Candales AL; Carron C; Schwartz J
Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
[TBL] [Abstract][Full Text] [Related]
13. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
[TBL] [Abstract][Full Text] [Related]
14. Intermittent inotropes for advanced heart failure: inquiring minds want to know.
Silver MA
Am Heart J; 1999 Aug; 138(2 Pt 1):191-2. PubMed ID: 10426825
[No Abstract] [Full Text] [Related]
15. The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
Klein G; Sauer E; Bauer R; Wirtzfeld A; Sebening H
Arzneimittelforschung; 1981; 31(1a):257-9. PubMed ID: 7195236
[No Abstract] [Full Text] [Related]
16. [Duchenne muscular dystrophy].
Ishihara T
Ryoikibetsu Shokogun Shirizu; 2001; (35):14-7. PubMed ID: 11555892
[No Abstract] [Full Text] [Related]
17. Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Drazner MH; Solomon MA; Thompson B; Yancy CW
Am J Cardiol; 1999 Oct; 84(8):941-3, A7. PubMed ID: 10532519
[TBL] [Abstract][Full Text] [Related]
18. Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
Opasich C; Russo A; Mingrone R; Zambelli M; Tavazzi L
Eur J Heart Fail; 2000 Mar; 2(1):7-11. PubMed ID: 10742697
[TBL] [Abstract][Full Text] [Related]
19. [Becker muscular dystrophy].
Ishihara T
Ryoikibetsu Shokogun Shirizu; 2001; (35):18-22. PubMed ID: 11555904
[No Abstract] [Full Text] [Related]
20. Becker's muscular dystrophy and orthotopic heart transplantation: perioperative considerations.
Komanapalli CB; Sera V; Slater MS; Burdette M; Tripathy U; Brady G; Hegnell L; Ravichandran PS; Hershberger RE; Song HK
Heart Surg Forum; 2006; 9(2):E604-6. PubMed ID: 16543161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
